Preoperative use of an anticoagulant (Plavix, warfarin, lovenox, etc.)
History of hypersensitivity to EACA
History of thromboembolic event (e.g., PE or DVT)
History of renal insufficiency or failure
Congenital or acquired coagulopathy as evidence by INR >1.4 or PTT > 1.4 times normal, or Platelets <150,000/mm3 on preoperative laboratory testing
Use of hormone replacement therapy or hormonal contraceptive agents within days prior to surgery
Use of acetylsalicylic acid (ASA), antiplatelet agents within 7 days prior to surgery
Pregnant
Breastfeeding
Not received neuraxial anesthesia

NCT02257580_exc_T1
Temporal
Preoperative
NCT02257580_exc_T2
Drug
anticoagulant
NCT02257580_exc_T3
Drug
Plavix
NCT02257580_exc_T4
Drug
warfarin
NCT02257580_exc_T5
Drug
lovenox
NCT02257580_exc_T6
Scope
Plavix, warfarin, lovenox
NCT02257580_exc_T7
Condition
hypersensitivity
NCT02257580_exc_T8
Drug
EACA
NCT02257580_exc_T9
Condition
thromboembolic event
NCT02257580_exc_T10
Condition
renal insufficiency
NCT02257580_exc_T11
Condition
PE
NCT02257580_exc_T12
Condition
DVT
NCT02257580_exc_T13
Scope
PE or DVT
NCT02257580_exc_T14
Condition
al in lure
Co
NCT02257580_exc_T15
Qualifier
Congenital
NCT02257580_exc_T16
Qualifier
acquired
NCT02257580_exc_T17
Condition
coagulopathy
NCT02257580_exc_T18
Scope
Congenital or acquired
NCT02257580_exc_T19
Measurement
INR
NCT02257580_exc_T20
Value
 o s normal, or
NCT02257580_exc_T21
Measurement
PTT
NCT02257580_exc_T22
Value
> 1.4 times normal
NCT02257580_exc_T23
Scope
INR >1.4 or PTT > 1.4 times normal
NCT02257580_exc_T24
Measurement
Platelets
NCT02257580_exc_T25
Value
<150,000/mm3
NCT02257580_exc_T26
Procedure
preoperative laboratory testing
NCT02257580_exc_T27
Procedure
hormone replacement therapy
NCT02257580_exc_T28
Drug
hormonal contraceptive agents
NCT02257580_exc_T29
Temporal
within days prior to surgery
NCT02257580_exc_T30
Reference_point
surgery
NCT02257580_exc_T31
Scope
hormone replacement therapy or hormonal contraceptive agents
NCT02257580_exc_T32
Drug
acetylsalicylic acid
NCT02257580_exc_T33
Drug
ASA
NCT02257580_exc_T34
Drug
antiplatelet agents
NCT02257580_exc_T35
Temporal
within 7 days prior to surgery
NCT02257580_exc_T36
Reference_point
surgery
NCT02257580_exc_T37
Scope
acetylsalicylic acid (ASA), antiplatelet agents
NCT02257580_exc_T38
Condition
Pregnant
NCT02257580_exc_T39
Observation
Breastfeeding
NCT02257580_exc_T40
Procedure
neuraxial anesthesia
NCT02257580_exc_T41
Negation
Not received